UK to face short-term delay in delivery of the Pfizer vaccine

Support us and go ad-free

The UK is set to face short-term delays in delivery of the Pfizer coronavirus (Covid-19) vaccine as the pharmaceutical company upgrades its production capacity.

Delays

Pfizer is upscaling production at its plant in Puurs, Belgium. This is in an to produce more doses than originally planned for 2021 – temporarily reducing deliveries to all European countries. Shipments of the vaccine, produced in partnership with Germany’s BioNTech, to the UK are set to be affected during January. But the overall number of doses due to be delivered between January and March will remain the same, according to the US firm.

HEALTH Coronavirus
(PA Graphics)

In response, a spokesperson for the government said that it’s still working to its plan of vaccinating all four priority groups by 15 February.

The vaccine from Pfizer is not the only candidate available in the UK, with the University of Oxford and AstraZeneca jab also currently being rolled out.

Read on...

Support us and go ad-free

Quarter one

A Pfizer spokesperson said:

We understand a change to deliveries has the potential to create uncertainty. However, we can confirm the overall projected volumes of delivery to the UK remain the same for quarter one (January to March).

We continue to liaise with the UK Government and the Vaccines Taskforce to work through short-term impact of these changes to our January deliveries and support the goals of the UK Covid-19 vaccination programme.

The UK has secured 40 million doses of the vaccine from Pfizer and BioNTech.

A government spokesperson said:

We are in the process of understanding the implications of Pfizer’s announcement today to our plans. However we continue to plan to hit our target of vaccinating all four priority groups by February 15.

Support us and go ad-free

We need your help to keep speaking the truth

Every story that you have come to us with; each injustice you have asked us to investigate; every campaign we have fought; each of your unheard voices we amplified; we do this for you. We are making a difference on your behalf.

Our fight is your fight. You’ve supported our collective struggle every time you gave us a like; and every time you shared our work across social media. Now we need you to support us with a monthly donation.

We have published nearly 2,000 articles and over 50 films in 2021. And we want to do this and more in 2022 but we don’t have enough money to go on at this pace. So, if you value our work and want us to continue then please join us and be part of The Canary family.

In return, you get:

* Advert free reading experience
* Quarterly group video call with the Editor-in-Chief
* Behind the scenes monthly e-newsletter
* 20% discount in our shop

Almost all of our spending goes to the people who make The Canary’s content. So your contribution directly supports our writers and enables us to continue to do what we do: speaking truth, powered by you. We have weathered many attempts to shut us down and silence our vital opposition to an increasingly fascist government and right-wing mainstream media.

With your help we can continue:

* Holding political and state power to account
* Advocating for the people the system marginalises
* Being a media outlet that upholds the highest standards
* Campaigning on the issues others won’t
* Putting your lives central to everything we do

We are a drop of truth in an ocean of deceit. But we can’t do this without your support. So please, can you help us continue the fight?

The Canary Support us
  • Show Comments
    1. You have missed the main point, which is that Pfizer has publicly stated that there is no scientific basis to justify delaying the second jab from 21 days after the first to within 3 months of the first. Efficacy will decline as a consequence. The Etonian/Oxbridge mafia and their supine medical advisers are again relying for a positive result on guesswork rather than science!

    Leave a Reply

    Join the conversation

    Please read our comment moderation policy here.